CAS No. : 72707-66-5
(Synonyms: α-(Bromomethyl)acrylic acid; α-Methylated acrylamide; α-MAA)
| Size | Price | Stock |
|---|---|---|
| 250mg | $45 | In-stock |
| 1g | $84 | In-stock |
| 5g | $276 | In-stock |
| 10g | $450 | In-stock |
| 25g | $963 | In-stock |
| 50 g | Get quote | |
| 100 g | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-W017180 |
| M.Wt: | 164.99 |
| Formula: | C4H5BrO2 |
| Purity: | >98 % |
| Solubility: |
2-(Bromomethyl) acrylic acid is a Bruton's tyrosine kinase (BTK) inhibitor. 2-(Bromomethyl) acrylic acid forms a covalent bond with the cysteine 481 (Cys481) residue of BTK via a nucleophilic addition-elimination reaction, thereby inhibiting the downstream B-cell receptor signaling pathway. 2-(Bromomethyl) acrylic acid induces immunogenic cell death in BTK-expressing B-cell lymphoma cells by releasing damage-associated molecular patterns including extracellular ATP and HMGB1. 2-(Bromomethyl) acrylic acid exhibits cytotoxicity against BTK-expressing B-cell lymphoma cells, but shows low toxicity to BTK-negative cells. 2-(Bromomethyl) acrylic acid can be used in studies related to B-cell lymphoma[1]. In Vivo:Ibt-DOX (2.5 mg/kg; i.v.; once every 2 days; 14 days) reduces subcutaneous OCI-LY10 xenograft tumor volume by 54% in female SCID mice, with no significant weight loss or toxicity observed[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.